Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a note stating 'No longer looking for participants', signaling that enrollment for this study has closed. This contextualizes the study's current recruitment status for potential participants browsing the page.SummaryDifference0.6%

- Check8 days agoChange DetectedThe page footer credits were updated to remove the Moffitt branding and 'Helpful Links Provided by' attribution, and a new revision tag (Revision: v3.5.5) was added.SummaryDifference0.2%

- Check16 days agoChange DetectedThe related topics section loses entries for Melanoma and MedlinePlus Genetics and the related topics header is removed. This reduces cross-links to those topics on the page.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedMelanoma is added as a topic with related topics: MedlinePlus Genetics. The page revision tag is updated to v3.5.4 (replacing v3.5.3).SummaryDifference0.2%

- Check37 days agoChange DetectedRemoved the related topics block containing Melanoma and the MedlinePlus Genetics link, including the 'related topics' label. This reduces navigational links on the study page without changing the core trial data.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page’s supporting footer section now lists updated MedlinePlus-related topic links (including MedlinePlus Genetics), and the displayed ClinicalTrials.gov revision version has been updated. This reflects a site/content wrapper update rather than any change to the underlying trial record.SummaryDifference0.2%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.